University General Hospital of Larissa

Larissa, Thessaly 41110

1 studies enrolling now · 6 studies all time

What they study most

ALK+ Advanced NSCLC, Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Cluster Headache, Episodic, Complicated Urinary Tract Infection (cUTI), Complicated Urinary Tract Infections, Gram-negative Bacterial Infections, Hospital Acquired Bacterial Pneumonia (HABP), Patients With Non-Small Cell Lung Cancer, Ventilator Associated Bacterial Pneumonia (VABP)

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer — Completed
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants — Completed
• Eptinezumab in Participants With Episodic Cluster Headache — Completed
• Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs) — Completed